Mechanism of Astragaloside A Against Lung Adenocarcinoma Based on Network Pharmacology Combined with Molecular Dynamics Simulation Technique
April 2025
in “
Scientific Reports
”
Studysummary This study explores how Astragaloside A from traditional Chinese medicine may combat lung adenocarcinoma by regulating key signaling molecules like STAT3 and AKT, using techniques such as network pharmacology and molecular docking to understand its mechanisms in cellular models. Our plain-language summary of this paper — not a Tressless recommendation.
This study investigates the mechanisms of Astragaloside A (AS-A), a component of Astragalus, in combating lung adenocarcinoma using network pharmacology and molecular dynamics. A protein-protein interaction network identified 10 key targets, including STAT3 and AKT1, involved in oxidative stress and the PI3K-Akt signalling pathway. Molecular docking and dynamic simulations assessed AS-A's binding stability with these targets, showing stable protein-ligand complexes. Cell experiments confirmed AS-A's ability to regulate key signalling molecules in lung adenocarcinoma models. The findings offer insights into AS-A's anticancer mechanisms and suggest new research directions for traditional Chinese medicines.
